A human IgE bispecific antibody shows potent cytotoxic capacity mediated by monocytes

The generation of bispecific antibodies (bsAbs) targeting two different antigens opens a new level of specificity and, compared to mAbs, improved clinical efficacy in cancer therapy. Currently, the different strategies for development of bsAbs primarily focus on IgG isotypes. Nevertheless, in compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Vukovic, Natasa, Halabi, Samer, Russo-Cabrera, Joan Salvador, Blokhuis, Bart, Berraondo, Pedro, Redegeld, Frank A.M., Zaiss, Dietmar M.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293656/
https://www.ncbi.nlm.nih.gov/pubmed/35718062
http://dx.doi.org/10.1016/j.jbc.2022.102153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293656/
https://www.ncbi.nlm.nih.gov/pubmed/35718062
http://dx.doi.org/10.1016/j.jbc.2022.102153

Ejemplares similares